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To investigate the impact of stress kinase p38 activation on HSV-1 transcription, we performed a global transcript profile analysis of viral
mRNA using an oligonucleotide-based DNA microarray. RNA was isolated from Vero cells infected with the KOS strain of HSV-1 in the
presence or absence of SB203580, a pyridinyl imidazole inhibitor of p38. Under conditions that eliminated ATF2 activation but had no effect
on c-Jun, and reduced virus yield by 85–90%, no effect on accumulation of viral IE, DE, or L transcripts was observed by array analysis or
selected Northern blot analysis at 2, 4, and 6 h post infection. Results of array data from cells infected with the ICP27 mutant d27-1 in the
presence or absence of SB203580 only reflected the known restricted transcription phenotype of the ICP27 mutant. This result is consistent
with a role for p38 activation on virus replication lying downstream of the essential role of ICP27 in DE and perhaps late transcription
regulation. No effect of SB203580 on transcription was detected after infection with the ICP0 mutant 7134, at 0.5 or 5.0 PFU/cell, though
decreases in the rate of accumulation of all kinetic classes of mRNA could be detected, relative to wt virus. These results indicate that
inhibiting p38 activity in Vero cells, while significantly reducing wt virus yield, demonstrated no obvious impact on the program of viral
transcription.
D 2004 Elsevier Inc. All rights reserved.
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The well-characterized time-dependent transcriptional
program of HSV-1 is regulated by viral and cellular factors
(Davido and Leib, 1998; Kim and DeLuca, 2002; Millhouse
et al., 1998; Pande et al., 1998; Soares et al., 1996; Weir,0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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California, Los Angeles, CA 90089, USA.2001; Wysocka and Herr, 2003). The virion-associated factor
VP16, in association with two cellular factors Oct1 and HCF,
promotes expression of the immediate-early (IE) mRNAs
encoding ICP0, 4, 27, 22 and 47. Copies of the cis-acting
TAATGARAT sequence which mediates VP16/Oct1/HCF
binding and IE expression, are present multiple times in each
IE gene promoter. Accumulation of ICP4 and ICP27 activates
delayed-early gene expression, followed by initiation of
DNA replication and late (L) gene expression. The L genes
can be further sub-divided into those whose expression is
either increased by (g1 genes), or absolutely dependent (g2
genes) on DNA replication.
Despite these virus-encoded processes, which can circum-
vent general cellular transcriptional repression, the replica-04) 142–156
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subject to the cellular transcriptional environment. The most
important biological manifestation of this cell dependence is,
of course, latency and stress-induced reactivation in sensory
neurons [see (Wagner and Bloom, 1997) for review], (Frazier
et al., 1996; Millhouse et al., 1998; Soares et al., 1996). Other
evidence for potential dependence of HSV replication on
cellular events can be seen in the multiplicity and cell cycle
dependence for replication of mutants lacking the immediate-
early ICP0 gene (Cai and Schaffer, 1991; Everett et al., 2004;
Ralph et al., 1994; Stow and Stow, 1986), and the ability of
cellular stress agents to initiate the transcriptional cascade by
induction of immediate early gene expression in the absence
of aTIF-induced activation [(Yang et al., 2002) and
references therein].
Metazoan genomes encode a large family of protein
kinases (collectively called the mitogen-activated protein
kinases, or MAPKs) that integrate external cues, and
propagate intracellular signals that trigger a transcriptional
response (Johnson and Lapadat, 2002). Growth promoting,
growth inhibiting, differentiating, and death inducing
factors, as well as stress-inducers such as ultraviolet light,
changes in osmotic pressure, and viral infection can activate
one or more of these signal transduction protein kinase
pathways. For example, the canonical growth-promoting
pathway is triggered by growth factor-receptor interaction at
the cell surface, intracellular activation of the small receptor-
associated GTP-binding protein RAS, followed by sequen-
tial activation of the serine-threonine MAPK kinase kinase
(MAPKKK) RAF, the dual-specificity threonine/tyrosine
MAPK kinase (MAPKK) MKK1 and the MAPKs ERK1/2.
Substrates of ERK include nuclear transcription factors
ELK, MYC, and cFos, as well as the cytoplasmic kinases
Mnk1/2. While the nature of stress signal receptors and
initiating kinases is less well understood, one such pathway
involves the MAPKKKs MEKK1 or MEKK4 (also known
as mixed-lineage kinases, MLKs), the MAPKK MKK4, and
the stress-activated kinase (SAPK) p38 (Gallo and Johnson,
2002). This serine/threonine kinase is reported to directly
phosphorylate the transcription factor ATF2, and indirectly
CREB and STAT1, the latter two through activation of two
downstream kinases, Msk1 and MAPKAPK-2 (Deak et al.,
1998; Goh et al., 1999; Li et al., 2004; Ramsauer et al.,
2002; Rolli et al., 1999; Wiggin et al., 2002).
Two SAPKs, p38 and Jun N-terminal kinase (JNK), are
activated following HSV-1 infection [(McLean and Bach-
enheimer, 1999; Zachos et al., 1999), and Hargett, McLean
and Bachenheimer, manuscript in preparation], the latter
mediated by MKK4 (Zachos et al., 1999). Activation of
both SAPKs is dependent on immediate-early (IE) viral
gene expression (McLean and Bachenheimer, 1999), and in
particular on functional ICP27 (Hargett, McLean and
Bachenheimer, MS in preparation). Activation of both p38
and JNK contributes to the over-all efficiency of virus
replication (McLean and Bachenheimer, 1999; Zachos et al.,
2001).While cognate binding sites for additional cellular
transcription factors, including CBP, HiNF-P, NF-nB,
AP1, and Sp1 can be identified in lytic viral gene promoters
(Deb et al., 1994; Pande et al., 1998; Rong et al., 1992), our
understanding of how these sites contribute to the pattern of
IE, DE and L gene expression is incomplete. One study of
the effect of deleting a portion of the ICP0 promoter
containing several cellular transcription factor binding sites
indicated that while the level of ICP0 expression and in vivo
virulence of the resulting virus were decreased significantly,
measures of latency establishment and reactivation were
unaffected (Davido and Leib, 1996). Progress has been
made in defining promoter modules of delayed-early
promoters (Imbalzano and DeLuca, 1992; Imbalzano et
al., 1991; Pande et al., 1998). In each case studied in detail,
an essential downstream module, containing at a minimum
the TATA box, and an essential or augmenting upstream
module, consisting of one or more Sp1 sites, participate in
activated expression of the gene. In the case of the TK gene,
regulation of both temporal and activated expression may be
governed by the phosphorylation state of Sp1 (Kim and
DeLuca, 2002).
Transcription factor AP-1 activity increases following
HSV infection (Jang et al., 1991). Consisting most
commonly as homodimers of Jun family members, or
heterodimers of Jun and Fos family members, AP-1 binds
the TPA-responsive element (TRE) TGACTCA. An activa-
tion target of JNK, c-Jun, can also heterodimerize with
CREB family members such as ATF2, and these complexes
bind the related cyclic AMP-responsive element (CRE)
TGACGTCA. Reporter genes regulated by either AP1 or
CRE sites are activated following HSV infection (McLean
and Bachenheimer, 1999). The promoter of the UL9 gene
contains a CRE site and was reported to be responsive to
addition of dibutyryl cyclic AMP in a transient reporter
assay (Deb et al., 1994).
One model explaining the contribution of SAPK
activation to HSV-1 replication predicts that p38 and JNK
affect directly or indirectly the viral transcriptional program
because of their ability to activate cellular transcription
factors ATF-2 and c-Jun, respectively. These considerations
prompted us to initially ask whether inhibition of p38
function affected the transcriptional program of HSV. To test
this hypothesis, we compared the kinetics of accumulation
of viral IE, DE, and L transcripts in the presence or absence
of SB203580, a pyridinyl imidazole drug that specifically
inhibits p38 activity (Cuenda et al., 1995; Young et al.,
1997).Results
SB203580 selectively inhibits activation of the p38
The pyridinyl imidazole compound SB203580 (SB)
selectively inhibits the ability of p38 to phosphorylate,
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to be a selective inhibitor of p38 function by compet-
itively inhibiting ATP binding in the catalytic pocket
(Young et al., 1997). Activation of the transcription factor
ATF2 can occur through phosphorylation by either p38 or
JNK (Gupta et al., 1995; Livingstone et al., 1995; van
Dam et al., 1995). Phosphorylation of p38 and JNK by
their upstream MAPKKs, as well as activation of ATF2
and c-Jun can be monitored with phospho-specific anti-
bodies. Because we wished to use SB to selectively
inhibit p38 function and thus prevent activation of ATF2,
we compared the phosphorylation status of ATF2, a p38
substrate, with phosphorylation of the JNK substrate, c-
Jun. Lysates prepared from cells treated either with SB, or
the diluent DMSO, and then mock infected, or infected
with wt KOS or the ICP27 mutant d27-1 were fractio-
nated by SDS-PAGE, Western blotted and probed for total
and phosphorylated ATF2 and c-Jun (Fig. 1). Relative
changes in the amounts of proteins were quantified by
ImageJ analysis of autoradiograms as described in
Materials and methods. Under our standard conditions of
mock infection, low levels of activated p38 (pp38, lane 1)
and JNK (pJNK, lane 7) were detectable in Vero cells. SB
treatment resulted in a 43% increase in the level of
phosphorylated p38 (pp38) when normalized to total p38,
but as expected the amount of activated ATF2 (pATF2) was
reduced more than 88% in the presence of the p38 inhibitor
(pATF2, lanes 1 and 2). The drug had no effect on levels of
phosphorylated JNK (pJNK) or activated c-Jun (pc-Jun,
lanes 7 and 8) in mock-infected cells. Following infection
with wt HSV, activated p38 and JNK, when normalized to
total p38 and JNK, increased both in the absence (150% and
118%, respectively) and presence (59% and 56%, respec-
tively) of SB (lanes 3, 4, 9, and 10), relative to the mock-
infected control samples. We detected a 100% increase in
activated ATF2 after wt HSV infection compared to mockFig. 1. Effect of p38 inhibitor SB203580 on transcription factor targets of p38
and JNK. Sets of replicate monolayers of Vero cells were pretreated for 30
min with either SB203580 (10 AM) in DMSO or with an equivalent volume
of DMSO, and then either mock infected, or infected with wt KOS or d27-1.
Incubation with drug or DMSO continued until 8 h pi, when whole cell
lysates were prepared, fractionated by SDS-PAGE, transferred to membranes
and probed for the indicated proteins by Western blot, as described in
Materials and methods. Short arrows point to phosphorylated isoforms of
JNK, the corresponding total JNK bands, and phosphorylated c-Jun in lanes
9–10; dots indicate phosphorylated ATF2 and the corresponding band in
total ATF2 in lane 3. pp38: phosphorylated p38; pATF2: phosphorylated
ATF2; pJNK: phosphorylated JNK; pc-Jun: phosphorylated c-Jun.infection (lanes 1 and 3) including at least one form with
reduced mobility relative to the majority of total ATF2.
Importantly, when normalized to total ATF2, the amount of
activated ATF2 was substantially reduced when wt infection
was performed in the presence of SB (49%, lanes 3 and 4).
In contrast the drug had only a slight effect on the level of
activated c-Jun (5%, lanes 9 and 10), when normalized to
total c-Jun. We have determined that expression of the IE
viral protein ICP27 is necessary for activation of both p38
and JNK (Hargett and Bachenheimer, manuscript in
preparation). As expected, infection with the ICP27 mutant
d27-1 failed to activate either ATF2 (lanes 5 and 6) or c-Jun
(lanes 11 and 12) over levels seen in mock-infected control
samples. These results indicate that treatment of cells with
SB203580 resulted in the expected inhibition of ATF2
activation, with little detectable effect on JNK function as
indicated by c-Jun activation.
Effects of MAPK inhibitors on virus yield in Vero cells
We previously demonstrated a role for JNK activation in
promoting efficient virus yield. Over-expression of the JNK
scaffold protein JIP-1 forced cytoplasmic retention of JNK,
failure to phosphorylate and thus activate nuclear c-Jun, and
decreased virus yield by 70% (McLean and Bachenheimer,
1999). In three independent experiments, we compared the
effect of the p38 inhibitor SB203580 with the vehicle control
DMSO (Table 1). In one of the experiments, we also
compared the effect of SB203580 with the JNK inhibitor
SP100625, and the ERK inhibitor UO126 to determine the
impact of activation of additional MAPKs on virus yield in
Vero cells. Freeze–thaw lysates were prepared at several
times post infection (pi), and virus yield determined by
standard plaque assay as described in Materials and methods.
The results indicated that both the p38 and JNK inhibitors,
but not the ERK inhibitor significantly impacted virus yield.
Specifically, virus yield at 24 h was reduced 60% to 86%
following SB203580 treatment and 90% following
SP100625 treatment. The impact of 10 AM SB203580 on
virus yield in Vero cells was greater than that reported for
the drug used at 30 AM in BHK cells and HeLa cells
(Zachos et al., 2001), suggesting cell type-specific effects of
p38 inhibition on virus replication. The presence of the ERK
inhibitor, UO126 resulted in significant increases in virus
yield compared to the DMSO control at both 8 and 16 h, pi.
The decreased yield at 24 h may reflect a decrease in the
activity of the drug by this time post addition. At earlier
times, the ability of UO126 to affect virus yield was
consistent with results [(McLean and Bachenheimer, 1999),
Hargett, McLean and Bachenheimer, unpublished] indicat-
ing that the MAPK pathway leading to ERK activation is
inhibited following HSV-1 infection. Together, these results
suggest that inhibition of the ERK pathway is important for
efficient virus replication, in contrast to our results with the
JNK and p38 pathways, indicating that their activation
contributes to efficient virus replication.
Table 1
Virus yield following treatment with MAPK inhibitorsa
Experiment #1b MOI = 5 Experiment #2b MOI = 5
SB203580 h, pi pfu/culture % reduction pfu/culture % reduction
 8 1.22  105 F 0.39 – 6.22  106 F 0.54 –
+ 8 1.02  105 F 0.58 16 3.63  106 F 1.2 41
 16 2.13  106 F 0.64 – 7.70  107 F 1.3 –
+ 16 1.72  106 F 0.56 19 3.00  107 F 1.0 61
 24 5.87  106 F 0.54 – 6.95  107 F 0.56 –
+ 24 2.15  106 F 0.82 63 2.78  107 F 0.67 60
Experiment #3c MOI = 5
SB203580 h, pi pfu/culture % reduction/(increase)
d 4 4.22  105 F 0.47 –
+ 4 3.8  105 F 1.2 10
 8 1.10  107F0.16 –
+ 8 3.93  106 F 1.9 64
 16 3.58  108 F 0.24 –
+ 16 4.96  108 F 1.4 (27)
 24 9.00  108 F 0.03 –
+ 24 1.22  108 F 0.21 86
UO126
+ 4 3.87  105 F 0.39 8
+ 8 3.19  107 F 1.5 (190)
+ 16 1.3  109 F 0.16 (263)
+ 24 5.93  108 F 1.1 34
SP100625
+ 4 2.77  105 F 1.4 34
+ 8 2.02  106 F 0.42 81
+ 16 1.54  108 F 0.16 56
+ 24 7.82  107 F 3.0 91
a Replicate cultures of Vero cells were pretreated with DMSO or MAPK inhibitors SB203580, SP600125, or UO126 for 30’ before infection with HSV-1
KOS. Incubation in DMSO or drug was continued for the indicated times when medium and cells were harvested and lysates prepared. Titer of infectious virus
was determined on Vero cells. The % increase or decrease was calculated by dividing the difference between control and drug treated values by the control
value 100. Plaque assays were performed as described in Materials and methods.
b Values derived from the average of duplicate cultures.
c Values derived from the average of triplicate cultures.
d Virus yields at various times post infection in the presence of DMSO were used to calculate % reduction or increase in virus yield for all three drugs.
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To assess the impact of inhibition of p38 SAPK on the
transcriptional program of HSV-1, we performed a global
analysis of viral mRNAwith an oligonucleotide-based DNA
microarray (Stingley et al., 2000; Wagner et al., 2002; Yang
et al., 2002). To succinctly present the large quantity of data
generated by such analyses, we have presented it graphically
showing only those probes that are diagnostic for a single
transcript or family of transcripts that are kinetically the
same. A tabular compilation of each group of experimental
data is available at the following URL: http://mendel.gti.
ed.ac.uk:8080/GPX/cgi-bin/gpx.cgi. We used these values
to carry out statistical analyses (t test). This procedure has
been described in earlier papers (Stingley et al., 2000;
Wagner et al., 2002; Yang et al., 2002).
To verify adequate sensitivity for detection of changes
in transcript abundance, array analyses were performedwith RNA prepared at 2 and 6 h pi after low (0.5 pfu/cell)
and high (5 pfu/cell) multiplicity infections with the ICP0-
null mutant, 7134; these data are shown in Fig. 2. At 2 h
pi following high MOI infection (panel A) only IE
transcripts for ICP27, ICP4, ICP22, and ICP47 accumu-
lated to high levels; this differs from a wt infection such as
shown in Fig. 3 notably in the decreased accumulation of
DE and L transcripts relative to levels of IE transcripts.
Indeed, at this time following infection, such a delayed
onset of DE and L transcripts is reminiscent of that seen in
infections with mutants lacking the VP16 activation
domain at 2 h after infection (Yang et al., 2002). While
protein lysates prepared from 7134-infected cells did not
contain any ICP0 based on Western blot (data not shown),
we did see a low hybridization signal with the ICP0 probe.
The 7134 mutant contains the lacZ gene in place of the
ICP0 coding sequences, but retains the sequences of both
5V and 3VUTRs (Cai and Schaffer, 1989). The ICP0 oligos
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Relative accumulation of IE, DE and L transcripts at 6 h pi
(Fig. 2, panel B) more closely resembled the pattern seen
at 4 h rather than 6 h pi with wt virus (Figs. 3C, D). This
is consistent with a delay in the kinetics of the viral
transcription program with this mutant even at MOI = 5.
Analysis of 2 h and 6 h mRNA from cells infected with
ICP0 mutant 7134 at a MOI = 0.5 (Figs. 2C, D), indicated
a severely reduced accumulation of all transcript classes
even at 6 h.
As shown in Fig. 3, and in contrast to these results, viral
transcript accumulation at 2, 4, and 6 h pi following
infection with wt KOS demonstrated nearly identicalFig. 2. Transcript accumulation in ICP0 mutant 7134 infected cells. Vero cells we
isolated at 2 or 6 h pi, and oligo-dT primed cDNA was prepared and hybridized
Stingley et al., 2000). X-axis: oligonucleotides representing HSV transcripts arran
LAT region of the RL). The bar representing signal from the ICP0 (RICP0) oligo is
5 pfu/cell 7134; (C and D): infection with 0.5 pfu/cell 7134. Panels A and C: RNpatterns of accumulation of IE, DE, and L transcripts
whether infections were performed in the presence (panels
A, C, E) or absence (panels B, D, F) of SB203580.
Numerical data for selected diagnostic transcripts are
tabulated both as normalized abundance levels and as
relative proportions of total transcript signal at the times
under study, and are shown in Table 2. Under these
conditions of infection, significant accumulation of most
DE and a few selected L transcripts was observed even at 2
h, and the abundance of transcripts from all classes
increased by 4 h. At 6 h pi, while the relative abundance
of IE and most DE transcripts declined, there were marginal
increases in the relative proportion of selected L transcripts,re infected with 0.5 or 5 pfu per cell with the ICP0 mutant 7134. RNA was
to an oligonucleotide-based DNA microarray as described in the text and
ged by kinetic class (black—IE; dark gray—DE; light gray—L; hatched—
unfilled. Y-axis: signal intensity in arbitrary units. (A and B): infection with
A isolated at 2 h pi; panels B and D: RNA isolated at 6 h pi.
Fig. 2 (continued).
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(hexon tips), UL44 (gC), and UL48 (VP16)—such changes
are entirely consistent with our global analyses of the HSV
transcription program (for example, see http://darwin.bio.
uci.edu/~faculty/wagner/hsv9fnew.html).
At both 2 and 4 h after infection with wt KOS, none of
the individual transcript groups showed any significant
difference (P b 0.05) when the drug and non-drug
treatments were compared, and there was no significant
difference in the total signals. At 6 h, the relatively small
difference between the sum of the median-relative signals
for all viral transcripts from drug and non-drug treatment
samples (460 k vs. 414 k) was measurably significant by
ANOVA (P = 0.025), but this was not manifest in
significant differences in any major hybridization signal.
Three probes specific for regions expressed in the LATprimary transcript (LAT-5V, RHA6, and orfOP) showed
essentially 2-fold higher total hybridization signals in the
drug treated vs. untreated controls, which was statistically
significant, but there was no corresponding difference seen
with the LATA and LATX probes which measure the
transcript level near the 3Vend.
The lack of effect of drug treatment on transcript
accumulation was verified by Northern blot analysis for
selected IE and DE viral transcripts (Fig. 4). Consistent with
the array results in Fig. 3, and the kinetic and metabolic
properties of IE and DE mRNAs, ICP0 and ICP27
transcripts were detectable at 2 h pi, while transcripts for
the DE essential replication proteins ICP8, UL5, UL42, and
UL30 were detectable initially at 4 h pi, and their relative
abundance was insensitive to the presence of either the p38
inhibitor SB203580, or the viral polymerase inhibitor PAA.
G. Karaca et al. / Virology 329 (2004) 142–156148Effect of SB203580 on ICP27 mutant d27-1 transcription
To confirm that p38 had no direct role in the transcrip-
tional program of HSV, we analyzed mRNA accumulation
at 6 h pi with the ICP27-null mutant d27-1 (Fig. 5). As
expected, global transcript analysis revealed significant
amounts of IE transcripts, with the exception of UL54, the
ICP27 gene, and the DE transcripts from UL1 (gL), UL23
(TK), UL27 (gB), UL29 (ICP8), UL39/40 (RR1/RR2),
UL50 (dUTPase), US2, and US8/9 genes (panel B). This
was in accord with a previous analysis of transcript
accumulation in the absence of ICP27 (Stingley et al.,
2000). When infection was performed in the presence of theFig. 3. Effect of p38 inhibitor SB203580 on wt HSV-1 transcription. Vero cells wer
HSV-1. RNAwas isolated and oligo-dT primed cDNAwas prepared and hybridize
Stingley et al., 2000). X-axis: oligonucleotides representing HSV transcripts arran
LAT region of the RL). Y-axis: signal intensity in arbitrary units. Panels A, C, and
the presence of DMSO. (A and B): 2 h infection; (C and D) 4 h infection; (E anp38 inhibitor SB203580, we observed no overall change in
the transcript profile, except for apparent increases in
transcripts encoding IE ICP0 (RICP0) and DE ribonucleo-
tide reductase large subunit (RR1/ICP6, UL39) (panel A).
The basis for this is currently unknown, but subsequent
Western blot analysis for protein accumulation under
identical conditions of infection, revealed no change in the
level of ICP0 in the presence of SB203580, compared to
infection in the presence of DMSO (data not shown).
Accumulation of transcripts for the g1UL46/g2UL47
(VP11/12 and VP13/14 VP16-associated proteins) L genes
may be explained by the fact that UL46 is a relatively
abundant transcript, which is clearly present by 2 h aftere infected in the presence or absence of the p38 inhibitor SB203580 with wt
d to an oligonucleotide-based DNA microarray as described in the text and
ged by kinetic class (black—IE; dark gray—DE; light gray—L; hatched—
E: infections in the presence of SB203580; panels B, D, and F, infections in
d F): 6 h infection.
Fig. 3 (continued).
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level, occurs in the absence of ICP27. The remaining pattern
of transcript accumulation was otherwise unchanged from
the DMSO control pattern.Discussion
The finding that HSV-1 infection activates the p38 and
JNK signal transduction pathways, prompted us to inves-
tigate the role of these SAPKs in transcription regulation.
These kinases are reported to phosphorylate, and thus activate
several transcription factors, most prominently ATF2, CREB
by p38, and c-Jun by JNK. In this report, we focused on p38
and the effect of the p38 inhibitor, SB203580 to affect the
transcriptional program of HSV-1. Using a global gene arrayapproach, we have demonstrated that inhibition of p38
function by this inhibitor did not quantitatively or kinetically
affect the IE, DE, and L viral transcript accumulation.
In a study directed at the role of p38 activation in the
evasion of the apoptotic response to HSVinfection (Zachos et
al., 2001), the impact of SB203580 on the accumulation of
several viral proteins was analyzed by Western blot.
Comparison of drug-treated and control samples harvested
at 6, 9, and 12 h pi, indicated a consistent 30F 10% decrease
in ICP0 protein in the presence of the p38 inhibitor, but no
difference in the levels of ICP4. At 9 h pi, a decrease in
ICP27, but not the DE protein UL42 was observed, and
decreases in DE UL40 (ribonucleotide reductase small
subunit/RR2) and L UL44 (gC), but not in IE/E UL39
(ribonucleotide reductase large subunit/RR1) were observed,
though the time point in these latter cases was not specified.
Fig. 3 (continued).
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mendel.gti.ed.ac.uk:8080/GPX/cgi-bin/gpx.cgi] indicate no
statistical difference between drug treated and control RNA
samples at 2, 4, and 6 h pi. Obvious differences between these
two analyses, besides assays employed for gene expression,
are the cell types (Vero vs. HeLa and BHK) and drug doses
(10 vs. 30 Ag/ml).
While the present experiments were being performed we
determined that expression of functional ICP27 in the
context of virus infection was sufficient for p38 activation
(Hargett, McLean and Bachenheimer, manuscript in prepa-
ration). Comparison of transcript accumulation during wt
KOS virus infection in the presence of SB203580, withaccumulation during d27 mutant virus infection indicated
that requirements for ICP27 in transcription regulation must
lay upstream of any effect of the drug on the viral replication
cycle: while the transcription program of wt virus was
unaffected, accumulation of viral transcripts in the absence
of ICP27 was restricted to the IE and DE classes. Early roles
of ICP27 have been noted for polyadenylation site selection
(Ellison et al., 2000; Hann et al., 1998; McGregor et al.,
1996; Sandri-Goldin and Mendoza, 1992), and transcription
of genes encoding viral DNA replication proteins (Uprichard
and Knipe, 1996). Late functions of ICP27 include reorgan-
ization of splicing factors (Lindberg and Kreivi, 2002;
Sandri-Goldin et al., 1995), nuclear-cytoplasmic shuttling
Table 2
Normalized and relative abundance of selected HSV-1 transcripts at 2, 4, and 6 h after infection in the presence or absence of the p38 inhibitor SB203580
Probe Controla SB203520b
2 h 4 h 6 h 2 h 4 h 6 h
medc SD reld medc SD reld medc SD reld medc SD reld medc SD reld medc SD reld
UL54 (IE) 17,600e 13,400 0.038 37,800 15,600 0.033 29,000 2300 0.026 23,900 7600 0.058 33,200 20,200 0.031 37,100 8600 0.032
RICP0 (IE) 9700 2900 0.021 9100 2800 0.008 14,300 2100 0.013 8700 4200 0.021 11,500 3200 0.011 19,500 4800 0.017
RICP4 (IE) 14,300 8800 0.031 23,600 11,000 0.021 11,400 6600 0.010 15,700 5200 0.038 21,900 4900 0.020 14,200 4500 0.012
US1 (IE22) 15,300 7800 0.033 50,400 10,800 0.044 39,800 5400 0.036 21,900 8300 0.053 40,300 17,700 0.037 39,800 6600 0.034
US12 (IE47) 16,300 8600 0.035 45,600 6800 0.040 34,500 3200 0.031 20,700 7000 0.050 37,200 8300 0.034 36,000 9300 0.031
UL23 (E) 15,900 6200 0.035 48,100 14,100 0.042 34,300 10,000 0.031 17,700 7200 0.043 38,500 20,100 0.036 32,900 5600 0.028
UL29 (E) 11,900 1800 0.026 24,900 25,900 0.022 19,300 4600 0.018 11,300 2600 0.027 31,000 8000 0.029 22,900 5100 0.020
UL30 (E) 9400 1700 0.021 17,400 2200 0.015 12,800 5100 0.012 6600 3000 0.016 17,400 4500 0.016 20,600 6100 0.018
UL39-5’ 13,000 9200 0.028 27,100 9100 0.024 21,700 6100 0.020 13,300 5700 0.032 25,400 4900 0.024 16,000 3000 0.014
UL43 (E) 3400 1400 0.008 12,100 18,500 0.011 3900 600 0.004 2000 1400 0.005 16,300 20,600 0.015 4300 1000 0.004
UL50 (E) 13,200 1000 0.029 39,900 10,500 0.035 33,100 4700 0.030 10,800 2100 0.026 32,600 10,600 0.030 30,500 2700 0.026
UL1 (L) 4200 2800 0.009 6900 7800 0.006 11,900 4400 0.011 3500 2100 0.008 9300 3300 0.009 17,400 4400 0.015
UL3 (L) 900 700 0.002 1300 1200 0.001 4600 1200 0.004 700 500 0.002 2600 2400 0.002 5200 1200 0.004
UL6 (L) 4000 2100 0.009 6300 4400 0.006 10,900 2500 0.010 3100 1900 0.007 6500 4700 0.006 11,900 2400 0.010
UL19/20 (L/L) 9400 3200 0.021 29,000 11,300 0.025 29,100 4800 0.027 10,500 2200 0.025 27,200 4600 0.025 25,900 3000 0.022
UL35 (L) 5800 2500 0.013 18,500 8900 0.016 27,400 2600 0.025 7400 2300 0.018 21,200 4000 0.020 29,500 3000 0.025
UL38 (L) 2700 1100 0.006 13,500 7100 0.012 15,200 2400 0.014 1600 1100 0.004 14,100 9800 0.013 15,800 5500 0.013
UL41 (L) 500 1100 0.001 2300 2700 0.002 11,900 4900 0.011 500 500 0.001 4700 2400 0.004 12,700 3100 0.011
UL48(L) 9900 3000 0.021 31,800 30,000 0.028 38,300 4000 0.035 10,600 1100 0.026 26,600 7100 0.025 43,300 7800 0.037
pLATX(LAT) 1800 1100 0.004 3400 1200 0.003 6600 2000 0.006 600 500 0.001 3600 1500 0.003 11,100 3500 0.009
Total signalf 459,500 1,137,000 1,096,600 413,600 1,078,700 1,172,000
a Infections were carried out in 0.5 AL/ml DMSO.
b See Materials and methods for details.
c Median and standard deviation of values of four independent normalized experiments.
d Relative level of transcript determined by the ratio of transcript signal to total signal.
e Abundance measured in arbitrary florescent units.
f Total of signals for all probes.
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Fig. 4. Northern blot analysis of viral transcripts Vero cells were infected
with wt HSV-1 KOS in the presence or absence of p38 inhibitor SB203580
or with the viral DNA polymerase inhibitor PAA (400 Ag/ml), or infected
with the ICP27 mutant d27-1. Cells were harvested at the indicated times
and RNA was isolated for Northern blot analysis as described in the text.
G. Karaca et al. / Virology 329 (2004) 142–156152and expression of late viral mRNAs (Bryant et al., 2001;
Chen et al., 2002; Koffa et al., 2001; Phelan and Clements,
1997; Soliman et al., 1997), and suppression of apoptosis
(Aubert and Blaho, 1999; Goodkin et al., 2003). Thus, it
seems likely that the role for ICP27-dependent p38
activation is not an adjunct to the role of ICP27 in
transcription or post-transcriptional processing. We cannot
at this time exclude roles for ICP27-dependent p38
activation in the export or translation of viral mRNA.
The mechanism of two linked aspects of viral gene
expression, temporal regulation, and activated expression
still lack adequate explanation. An underlying assumption in
models of regulation is that cellular transcription factors
play an important role in activated expression, given the
presence of their cognate binding sites in viral promoters. In
the context of virus infection the UL37 promoter contains a
downstream HiNF-P site and the UL50 (dUTPase) promoter
contains an upstream Sp1 site, both of which are essential
for activated expression. In contrast, the upstream Sp1 sites
of the DE UL23 (TK) and UL37 promoters only have
augmenting roles (Imbalzano and DeLuca, 1992; Imbalzano
et al., 1991; Pande et al., 1998). CRE sites, which bind Jun/
ATF heterodimers, occur in the intergenic regions upstream
of the UL9 and UL54 (ICP27) genes, upstream of the UL4
ORF, and in the middle of the UL15 ORF. None of these
sites have been shown to be critical for gene expression in
the context of virus infection.
The present study reinforces the notion that activation of
a transcription factor following virus infection does not
necessarily point to its critical role in activated expression of
viral genes. Four possible explanations for the failure to
detect a role for p38-dependent transcription factor activa-
tion in the context of virus infection can be considered.
First, perhaps alternative targets of p38, such as Msk1,
MapKap2, and Mnk1/2 kinases (Raught and Gingras, 1999;
Roux and Blenis, 2004) and their downstream targets, arerelevant for virus replication. Indeed, eIF4e activation in
HSV infected cells has been observed [(Walsh and Mohr,
2004), Hargett, McLean and Bachenheimer, unpublished
observations]. Second, the importance of activated ATF2
and AP-1 are masked in the tissue cultures models normally
used to study virus replication. Third, signal regulated
networks have the potential for cross-talk (Gupta et al.,
1995; Livingstone et al., 1995; van Dam et al., 1995), and
coupled with combinatorial redundancy of regulatory motifs
in viral promoters may well exhibit a high degree of
robustness even in the presence of a specific SAPK kinase
inhibitor. Fourth, the impact of activated p38 targets may be
masked by viral encoded factors such as VP16 and ICP0.
With regard to this latter possibility, the mutant in1820K
encoding a mutated VP16, the temperature sensitive allele
of ICP4 derived from the tsK mutant, and a substitution
mutation in the ICP0 promoter failed to express IE genes.
However when infected cells, incubated at 38.5 8C were
treated with protein synthesis inhibitors, both ICP0 and
ICP27 promoters were activated (Preston et al., 1998).
These are conditions that induce JNK and p38 (McLean and
Bachenheimer, 1999). Future studies will be directed at
addressing the role of stress kinase activation for HSV
replication under conditions that take into account these four
explanations.Materials and methods
Cells and virus
Vero cells were propagated in Dulbecco’s modified Eagle
medium (DMEM-H), supplemented with 5% calf serum,
100 U/ml penicillin, 1% streptomycin, and 1% l-glutamine
(all from Gibco).
Virus yield assay
Sub-confluent cultures were pretreated with the p38
inhibitor SB203580 (10 AM), the JNK inhibitor SP100625
(20 AM), the ERK inhibitor UO126 (10 AM), or the vehicle
control DMSO (0.5 Al/ml). Drug treatment was continued
during infection with HSV-1 strain KOS at MOI = 5, until
the time of harvest between 4 and 24 h post-infection (pi).
Following three cycles of freezing and thawing, monolayers
of Vero cells in 12 well dishes were inoculated in triplicate
with serial 10-fold dilutions of the lysates. After 1 h,
monolayers were covered with DMEM-H containing 2% CS
and 0.3% methylcellulose. After 3 days incubation at 37 8C,
medium was aspirated from the wells and plaques stained
with 0.8% crystal violet in 50% ethanol.
Global analysis of viral RNA
Replicate monolayers of Vero cells in 150 mm dishes
were infected with wt KOS at MOI = 5, in the presence or
Fig. 5. Transcript profile in ICP27 mutant d27 infected Vero cells. Vero cells were infected in the presence or absence of SB203580 with the ICP27 mutant d27-
1. RNAwas isolated at 6 h pi, and oligo-dT primed cDNAwas prepared and hybridized to an oligonucleotide-based DNA microarray as described in the text
and Stingley et al., 2000). X-axis: oligonucleotides representing HSV transcripts arranged by kinetic class (black—IE; dark gray—DE; light gray—L; black—
LAT region of the RL). Bar representing signal from the ICP27 (UL54) oligo is unfilled. Y-axis: signal intensity in arbitrary units. (A) d27-1 infection in the
presence of SB203580; (B) d27-1 infection in the presence of DMSO.
G. Karaca et al. / Virology 329 (2004) 142–156 153absence of SB203580 (10 AM). RNA was prepared from
cells harvested at 2, 4, and 6 h pi under these conditions
from three independent (separated in time) sets of infections
using Trizol. Isolated RNAwas further purified by pelleting
through a 5.7 M CsCl cushion by centrifugation for 16 h at
36,000 rpm in a Beckman SW41 rotor.
Fluorescence-labeled cDNA was prepared from 1 Ag
aliquots of purified poly(A)-containing RNA by random
hexamer-primed polymerization using Superscript II reverse
transcriptase (Gibco-BRL). The pool of nucleotides in the
labeling reaction consisted of 0.5 mM dGTP, dATP, and
dTTP and 0.3 mM dCTP and fluorescent nucleotides
(Cy3dCTP and Cy5dCTP; Amersham) at 0.1 mM. Fluo-
rescence-labeled DNA was purified by chromatography
through Microcon YM-20 columns (Amicon), then heatdenatured for 2 min at 100 8C, and incubated 20 to 30 min at
37 8C before use.
Characteristics of the HSV-1 specific oligonucleotide-
based DNA chip have described (Wagner et al., 2002).
Microarrays were hybridized for 16 h in 5 SSC–0.2% SDS
at 68 8C under coverslips with combined Cy5dCTP and
Cy3dCTP-labeled cDNA. The entire assembly was enclosed
in a commercial hybridization chamber (GeneMachines, San
Carlos, CA). After hybridization, the microarray slide
assembly was washed for 5 min in 1 SSC–0.2% SDS at
room temperature for 5 min, 5 min in 0.1 SSC–0.2% SDS at
room temperature, and 1 min in 0.1 SSC, and spun dry in a
low-speed centrifuge. Microarrays were scanned using a
confocal laser ScanArray 4000 system (General Scanning,
Inc.). Data were collected at a maximum resolution of 10 Am/
G. Karaca et al. / Virology 329 (2004) 142–156154pixel with 16 bits of depth by using Quantarray software
(General Scanning, Inc.).
The scanning process sampled the fluorescence (ex-
pressed in arbitrary units) derived from each spotted
oligonucleotide. These values were adjusted by subtracting
the background fluorescence of an equivalent area within a
concentric ring just outside the spotted sample. The data from
individual spots were then expressed in a Microsoft Excel
spreadsheet, and net values were determined by subtracting
the average of values obtained from measuring the fluo-
rescence of a large number (ca. 100) of regions spotted with
SSC alone. Typically, and depending on the exact laser power
of the scan, this SSC background ranged from 50 to 500
arbitrary units.
Weak fluorescent signals are inherently less reliable than
strong ones. Moreover, the ratio of fluorescent signal to
actual sample value is linear only to net (SSC) values of
40,000 or so. To accommodate these limitations, laser power
for scanning was adjusted for optimum signal sensitivity to
a laser power between 75 and 90 with the photomultiplier
set 5 units less than laser power. Standardization studies
have shown that increasing laser power by 5 units in the
range used increases those signals in the reciprocity range
approximately by a factor of 2. Multiple scans at varying
laser power settings were used to optimize all signals of
interest.
For comparison of data from the various experimental
conditions, the net (SSC) hybridization values were
compiled in several steps. First, in each separate experi-
ment (hybridization) and for each transcript set, a median
value was calculated from the three replicate probe spots
on a given chip. Two completely separate experiments
were carried out for each condition used, and each RNA
preparation was tagged with c3 and c5 in separate
experiments, and these were hybridized individually. Thus,
each data point was based on the median for the four
separate hybridization values. To compare data from
replicate experiments the 75th percentile rank for the total
viral hybridization was calculated. One experiment was
arbitrarily chosen as the reference and the 75th percentile
values of all other determinations were adjusted to this
value by appropriate factoring. In this way, chips belong-
ing to each experimental group are scaled accordingly. The
relative abundance of each transcript was calculated as the
quotient of the final median value for that transcript
divided by the sum of the median values for all viral
transcripts. These relative abundance values are displayed
as percentages. To compare expression levels under
different conditions, the sets of median values (or, in
some cases, the sets of relative abundance values) from all
replicates of the conditions being considered were eval-
uated using Student’s two-tailed t test, assuming unequal
variance and with the null hypothesis being that the true
values under those two conditions are identical. Tabular
data is available at http://mendel.gti.ed.ac.uk:8080/GPX/
cgi-bin/gpx.cgi.Northern blot analysis
RNA was isolated from mock and virus infected cells
using the RNeasy manufacturer’s protocol (Qiagen). RNA
(5 Ag aliquots) was fractionated on 1.4% formaldehyde
agarose gels, transferred to Biotrans nylon membranes
(ICN) with 20 SSC and subsequently covalently linked
to membranes by UV cross-linking. Plasmids containing
coding sequences for UL5 (pCMUL5), UL29/ICP8
(pSV8.3), UL30/pol (pCMUL30), UL42 (pCMUL42), and
UL54/ICP27 (pCMUL54) (Uprichard and Knipe, 1996)
were linearized with HindIII, and using specific primer sets,
probe sequences were amplified by PCR and then purified
using the QIAquick PCR purification manufacturer’s pro-
tocol (Qiagen). Probe sequences for ICP0 and ICP4 were
PCR amplified from EcoRI linearized pSG1 (Quinlan and
Knipe, 1985), and probe sequences for ICP27 were PCR
amplified from a Bam/Sal fragment derived from pRB112
(Post et al., 1980). Forward (F) and reverse (R) primer sets
(5V to 3V) (Sciortino et al., 2001) were as follows:
ICP0 (F) TGTTTCCCTGCGACCGAGACCT, (R) CAC-
TATCAGGTACACCAGCTTG;
ICP4 (F) GGCGGGAAGTTGTGGACTGG, (R)
CAGGTTGTTGCCGTTTATTGCG;
ICP27 (F) TAATTGACCTCGGCCTGGACCT, (R)
TGGGCTTTGGTCGGTGGGGGTT;
UL5 (F) TAATGACGTCATCGCGCTCGTG, (R)
ACGGGTGTTTGCCTTTGCGGAC;
ICP8 (F) TAGGTACTCGTCCTCCAGGAGC, (R)
ATGGTCGTGTTGGGGTTGAGCA;
UL30 (F) GGTGTATTACAAGCTCATGGCC, (R)
ACTCTCGGTGATCTTGGCGTTA; and
UL42 (F) GAACCAGCACCACAAAGCTCGT, (R)
GGGCGCCGAACTTAATGGAATC.
Labeled probe was generated by subjecting the PCR
products to a random priming reaction (Life Technologies)
containing a32PdCTP, and separated from unincorporated
nucleotides using ProbeQuant G-50 columns (Amersham
Pharmacia Biotech). Following prehybridization of filters at
42 8C for 30V in ULTRAhyb solution (Ambion) containing
20 mg/ml denatured salmon sperm DNA, labeled probe was
added, and hybridization continued for 18 h. Blots were
then washed in 2 SSC, 0.1% SDS for 10V, and 1SSC,
0.1% SDS for 5V. Filters were dried and exposed to XAR-5
film (Kodak) at 80 8C with intensifying screens.
Preparation of whole cell lysates and Western blot analysis
At the time of harvest, Vero cells were placed on ice to
prevent artifactual induction of stress responses. The
medium was removed and the monolayers rinsed with ice-
cold Dulbecco’s PBS. Cells were scraped directly into 1
SDS sample buffer [3.85 mM Tris-base (pH 6.8), 9.1% h-
mercaptoethanol, 1.82% SDS, 4.6% glycerol, and 0.023%
G. Karaca et al. / Virology 329 (2004) 142–156 155bromophenol blue (in 100% EtOH)] and denatured by
boiling. Cell-equivalent amounts of lysate were separated by
electrophoresis on 12% SDS-polyacrylamide gels (SDS-
PAGE). Proteins were transferred to PolyScreenR PVDF
membranes (Perkin-Elmer Life Sciences) followed by
blocking in TBST (150 mM NaCl, 20 mM Tris [pH 7.6],
0.05% Tween 20) with 5% milk. All probing and washing of
membranes was done in TBST. Antibodies for p38 (9212),
phospho-p38 (9211), JNK (9252), phospho-JNK (9251), c-
Jun (9162), phospho c-Jun (9261), ATF-2 (9222), and
phospho ATF-2 (9225) were purchased from Cell Signaling
Technology and used at a 1:1000 dilution overnight at 4 8C
per manufacturer’s instructions. Monoclonal antibody for a-
tubulin (B-5-1-2, Sigma) was used at a 1:20,000 dilution.
Goat anti-rabbit and anti-mouse secondary antibodies were
purchased from Amersham Biosciences. The secondary
antibody was detected with SuperSignal West Pico Chem-
iluminescent substrate agent (Pierce). Films were scanned
and images stored as 8-bit grayscale JPEG files. The density
of each band was determined using Image J (NIH). Relative
density values were corrected for average background by
subtracting out the density of a blank portion of the film.
The corrected values were then used to calculate percent
change from mock-infected cell or control cell levels.Acknowledgments
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